Drugs / Gamma Delta T-Cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05015426 | Mar 2022 → Aug 2025 overdue | acute myeloid leukemia | H. Lee Moffitt Cancer Center and Research Institute | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gamma Delta T-Cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05015426 ↗ |
| Route | Other | “administered as a single infusion” NCT05015426 ↗ |